Northern Trust’s Soleno Therapeutics SLNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.5M Buy
328,640
+96,304
+41% +$8.07M ﹤0.01% 1463
2025
Q1
$16.6M Buy
232,336
+5,447
+2% +$389K ﹤0.01% 1745
2024
Q4
$10.2M Buy
226,889
+34,309
+18% +$1.54M ﹤0.01% 2110
2024
Q3
$9.72M Buy
192,580
+136,185
+241% +$6.88M ﹤0.01% 2081
2024
Q2
$2.3M Buy
56,395
+22,427
+66% +$915K ﹤0.01% 2822
2024
Q1
$1.45M Buy
33,968
+650
+2% +$27.8K ﹤0.01% 3135
2023
Q4
$1.34M Buy
33,318
+26,288
+374% +$1.06M ﹤0.01% 3196
2023
Q3
$207K Buy
+7,030
New +$207K ﹤0.01% 3803
2022
Q3
Sell
-7,032
Closed -$20K 4756
2022
Q2
$20K Hold
7,032
﹤0.01% 4625
2022
Q1
$24K Hold
7,032
﹤0.01% 4652
2021
Q4
$43K Hold
7,032
﹤0.01% 4615
2021
Q3
$97K Hold
7,032
﹤0.01% 4409
2021
Q2
$120K Sell
7,032
-33,325
-83% -$569K ﹤0.01% 4319
2021
Q1
$763K Sell
40,357
-4,284
-10% -$81K ﹤0.01% 3688
2020
Q4
$1.29M Buy
44,641
+2,795
+7% +$80.9K ﹤0.01% 3406
2020
Q3
$1.58M Buy
41,846
+16,941
+68% +$638K ﹤0.01% 3169
2020
Q2
$830K Buy
24,905
+21,749
+689% +$725K ﹤0.01% 3417
2020
Q1
$113K Buy
3,156
+1,581
+100% +$56.6K ﹤0.01% 3795
2019
Q4
$69K Buy
+1,575
New +$69K ﹤0.01% 4008
2019
Q2
Sell
-775
Closed -$24K 4295
2019
Q1
$24K Hold
775
﹤0.01% 4117
2018
Q4
$20K Hold
775
﹤0.01% 4153
2018
Q3
$25K Hold
775
﹤0.01% 4202
2018
Q2
$27K Buy
+775
New +$27K ﹤0.01% 4189
2017
Q4
Sell
-192
Closed -$7K 4267
2017
Q3
$7K Hold
192
﹤0.01% 4214
2017
Q2
$7K Hold
192
﹤0.01% 4237
2017
Q1
$10K Buy
+192
New +$10K ﹤0.01% 4194